
1. j biol chem. 2006 dec 1;281(48):37150-8. epub 2006 sep 28.

human t-cell leukemia virus type p30 nuclear/nucleolar retention mediated
through interactions rna constituent 60 ribosomal subunit.

ghorbel s(1), sinha-datta u, dundr m, brown m, franchini g, nicot c.

author information: 
(1)department microbiology, molecular genetics, immunology, university 
kansas medical center, kansas city, kansas 66160-7420, usa.

human t-cell leukemia virus type etiological agent adult t-cell
leukemia/lymphoma, aggressive fatal lymphoproliferative malignancy. the
virus evolved strategies escape immune clearance remaining latent in
most infected cells vivo. demonstrated previously virally encoded p30 
protein potent post-transcriptional inhibitor virus replication (nicot,
c., dundr, m., johnson, j. m., fullen, j. r., alonzo, n., fukumoto, r., princler,
g. l., derse, d., misteli, t., franchini, g. (2004) nat. med. 10, 197-201).
p30 unable shuttle nucleus heterokaryon assays, suggesting
the existence specific retention signals. suppression virus
replication relies nuclear retention tax/rex mrna p30, determining
the retention features p30 offer hints break latency infected cells
and insights new therapeutic approaches. study, used live cell
imaging technologies study kinetics p30 delineate retention 
signals function virus replication. notably, first study
to identify p30 nucleolar retention domains. using mutants p30 localized 
in different cellular compartments, show post-transcriptional control 
virus replication p30 occurs nucleoplasm. demonstrate that
p30 nuclear/nucleolar retention dependent upon de novo rna transcripts and
interactions components ribosomal machinery.

doi: 10.1074/jbc.m603981200 
pmid: 17008317  [indexed medline]

